🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04077086
Active, not recruiting Not applicable

Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities

NCT04077086 · tracked via the Priya Life Science China tracker
Sponsor
Queen's University, Belfast
Phase
Not applicable
Started
2024-11-28
Last updated
2026-09-08

Condition(s) studied

Refractive Errors

Investigational drug(s) / intervention(s)

Spectacles

Spectacles: Intervention group children in middle school Year 1 will receive spectacles in December 2024. Assuming that the relevant effects of treatment (glasses wear) on the main study outcome are complete once examinations determining high school attendance are finished at the end of Middle School Year 3, Intervention participants will have undergone 32 months (December 2024 - July 2027) of treatment by the endpoint of the trial.

Study summary

Chinese children are some of the most short-sighted in the world, but only one in five children in poor areas who needs glasses has them. Our team has already shown in other trials that giving children free glasses leads to better grades and that free glasses have a bigger impact on grades than factors like parents' education level and the amount of money a family has. The effect on grades from glasses is greater than from other health services in school, like giving vitamins. Only about one in three children in rural China goes on to a regular, non-vocational high school. The investigators would like to show the Chinese government strong evidence of what glasses can do to help children continue their education, in order to help convince the government to carry out national programs to provide free glasses for children who need them.

Study Plan: The investigators will choose 111 middle schools at random in Liaoning, northern China, and all children in Year 1 at each school will go at random into one of two groups: either a group getting free glasses, with support from teachers to push them to wear the glasses ("Intervention") or a group getting just glasses prescriptions ("Control.") The main study outcome will be the proportion of children going on to academic (as opposed to vocational) high school, and the study is powered to detect a 10% difference in this figure between groups.The study will also assess whether children wear their glasses at school and how often they use blackboards (which disadvantage short-sighted children) vs textbooks to learn from. These other outcomes will help us to better understand the causal pathway between vision and high school attendance. We will also study the total cost of providing glasses and the teacher support to wear them per additional student attending academic high school, as well as student mental health outcomes. We will also collect data on the progression of nearsightedness. The hypothesis of this study is that providing glasses will increase academic high school attendance.

Eligibility

Sex
ALL
Min age
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Year 1 classes (likely age 12-15 years) at the recruited schools * Those who will be in the second year of middle school when the intervention begins the next year * Have uncorrected (without glasses/presenting) visual acuity of ≤6/12 in both eyes * Refractive error meets cut-offs shown to be associated with significantly greater improvement in visual acuity when corrected (myopia ≤-0.75 diopters (D, or astigmatism (non-spherical refractive error) ≥1.00 D) * Visual acuity can be improved to \>= 6/7.5 in at least one eye with glasses. Exclusion Criteria: * Hyperopia ≥ 2.00 D * Presence of visually-significant ocular condition besides refractive error

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
He Eye Specialist Hospital Shenyang Liaoning
Ningxia University Yinchuan Xixia
Centre for Public Health Belfast Northern Ireland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04077086 on ClinicalTrials.gov ↗ ← All trials in China